Worth LJ - Search Results

1

Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis.

Haeusler GM, Slavin MA, Seymour JF, Lingaratnam S, Teh BW, Tam CS, Thursky KA, Worth LJ. Haeusler GM, et al. Among authors: worth lj. Eur J Haematol. 2013 Aug;91(2):157-63. doi: 10.1111/ejh.12135. Epub 2013 Jun 15. Eur J Haematol. 2013. PMID: 23668894 Free PMC article.

2

Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

Thursky KA, Worth LJ, Seymour JF, Miles Prince H, Slavin MA. Thursky KA, et al. Among authors: worth lj. Br J Haematol. 2006 Jan;132(1):3-12. doi: 10.1111/j.1365-2141.2005.05789.x. Br J Haematol. 2006. PMID: 16371014 Free article. Review.

3

Cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab: prophylaxis vs. pre-emptive strategies for prevention.

Worth LJ, Thursky KA. Worth LJ, et al. Leuk Lymphoma. 2006 Dec;47(12):2435-6. doi: 10.1080/10428190601090436. Leuk Lymphoma. 2006. PMID: 17169785 No abstract available.

4

Catheter-related bloodstream infections in hematology: time for standardized surveillance?

Worth LJ, Slavin MA, Brown GV, Black J. Worth LJ, et al. Cancer. 2007 Apr 1;109(7):1215-26. doi: 10.1002/cncr.22527. Cancer. 2007. PMID: 17326048 Free article. Review.

5

Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.

Worth LJ, Thursky KA, Seymour JF, Slavin MA. Worth LJ, et al. Eur J Haematol. 2007 Sep;79(3):226-33. doi: 10.1111/j.1600-0609.2007.00911.x. Epub 2007 Jul 26. Eur J Haematol. 2007. PMID: 17655696

6

Surveillance for catheter-associated bloodstream infection in hematology units: quantifying the characteristics of a practical case definition.

Worth LJ, Black J, Seymour JF, Thursky KA, Slavin MA. Worth LJ, et al. Infect Control Hosp Epidemiol. 2008 Apr;29(4):358-60. doi: 10.1086/528879. Infect Control Hosp Epidemiol. 2008. PMID: 18462148

7

Bloodstream infections in haematology: risks and new challenges for prevention.

Worth LJ, Slavin MA. Worth LJ, et al. Blood Rev. 2009 May;23(3):113-22. doi: 10.1016/j.blre.2008.10.003. Epub 2008 Nov 28. Blood Rev. 2009. PMID: 19046796 Review.

8

Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices.

Worth LJ, Seymour JF, Slavin MA. Worth LJ, et al. Support Care Cancer. 2009 Jul;17(7):811-8. doi: 10.1007/s00520-008-0561-7. Epub 2008 Dec 19. Support Care Cancer. 2009. PMID: 19096883

9

Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.

Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, Harper JM, Thursky K, Worth LJ, Dwyer DE, Morrissey CO, Johnson PD, Buising KL, Harrison SJ, Seymour JF, Ferguson PE, Wang B, Denholm JT, Cheng AC, Slavin M. Tramontana AR, et al. Among authors: worth lj. Emerg Infect Dis. 2010 Jul;16(7):1068-75. doi: 10.3201/eid1607.091691. Emerg Infect Dis. 2010. PMID: 20587176 Free PMC article.

10

Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.

Abbott IJ, Slavin MA, Turnidge JD, Thursky KA, Worth LJ. Abbott IJ, et al. Among authors: worth lj. Expert Rev Anti Infect Ther. 2011 Apr;9(4):471-88. doi: 10.1586/eri.11.24. Expert Rev Anti Infect Ther. 2011. PMID: 21504403 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters